Clinical Trials - February 20, 2016
Preliminary interim report from Diamyd’s DIAGNODE-1
Diamyd Medical announces that the first six-month interim report from DIAGNODE-1, a clinical pilot study in which the diabetes vaccine Diamyd is administered directly into lymph nodes, preliminarily shows that the treatment appears to be safe and tolerable and that the clinical progression in patients is positive in terms of the body’s own capacity to […]
Clinical Trials - June 8, 2015
ALK Partner Testing Allergy Drug
ALK’s partner MSD has produced encouraging results from a North American Phase III clinical trial of ALK’s investigational sublingual allergy immunotherapy tablet for the treatment of house dust mite allergic rhinitis. The trial demonstrated a statistically significant improvement in the primary endpoint in favor of HDM SLIT-tablet compared with placebo, according to BioSpace.com. The primary endpoint […]
Collaboration - May 4, 2015
Recipharm, Follicum Ink Pact
Recipharm has signed an agreement of cooperation with Follicum AB prior to a clinical trial for the drug candidate FOL-005th, which is being developed to stimulate or inhibit hair growth for both men and women, without side effects. Recipharm has been commissioned to formulate and produce the product that will be used in the clinical […]
Clinical Trials - April 28, 2015
Trial Starts for PPMS Drug
Teva Pharmaceutical Industries Ltd. and Active Biotech enrolled the first patient in their study A RandomizedPlacebo-controlled Trial Evaluating Laquinimod in primary progressive multiple sclerosis (PPMS), Gauging Gradations In MRI and Clinical Outcomes (ARPEGGIO), a Phase II study to evaluate laquinimod. This is an investigational, oral, immune modulator, for PPMS, which currently has no approved treatments. PPMS affects approximately 15 percent of all MS patients […]
